Cyclophosphamide: An Overview
Cyclophosphamide (CPE) is an alkylating agent that has shown to have a wide range of applications in dermatology. Although not a first-line drug for any of the dermatological disorders, it has been found to be useful as a second-line drug in unresponsive cases. A major drawback of CPE is its toxicit...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Clinical Dermatology Review |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/cdr.cdr_89_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832087654157516800 |
|---|---|
| author | Aditya Kumar Bubna |
| author_facet | Aditya Kumar Bubna |
| author_sort | Aditya Kumar Bubna |
| collection | DOAJ |
| description | Cyclophosphamide (CPE) is an alkylating agent that has shown to have a wide range of applications in dermatology. Although not a first-line drug for any of the dermatological disorders, it has been found to be useful as a second-line drug in unresponsive cases. A major drawback of CPE is its toxicity profile. Nevertheless, if used with caution, it can prove to be of immense value in dermatologic practice. |
| format | Article |
| id | doaj-art-08ddc3afe0334f32b36725bc95ce73fe |
| institution | Kabale University |
| issn | 2542-551X 2542-5528 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Clinical Dermatology Review |
| spelling | doaj-art-08ddc3afe0334f32b36725bc95ce73fe2025-02-06T05:07:41ZengWolters Kluwer Medknow PublicationsClinical Dermatology Review2542-551X2542-55282025-01-01911810.4103/cdr.cdr_89_23Cyclophosphamide: An OverviewAditya Kumar BubnaCyclophosphamide (CPE) is an alkylating agent that has shown to have a wide range of applications in dermatology. Although not a first-line drug for any of the dermatological disorders, it has been found to be useful as a second-line drug in unresponsive cases. A major drawback of CPE is its toxicity profile. Nevertheless, if used with caution, it can prove to be of immense value in dermatologic practice.https://journals.lww.com/10.4103/cdr.cdr_89_23alkylating agentconnective tissue disorderscyclophosphamidevasculitisvesiculobullous disorders |
| spellingShingle | Aditya Kumar Bubna Cyclophosphamide: An Overview Clinical Dermatology Review alkylating agent connective tissue disorders cyclophosphamide vasculitis vesiculobullous disorders |
| title | Cyclophosphamide: An Overview |
| title_full | Cyclophosphamide: An Overview |
| title_fullStr | Cyclophosphamide: An Overview |
| title_full_unstemmed | Cyclophosphamide: An Overview |
| title_short | Cyclophosphamide: An Overview |
| title_sort | cyclophosphamide an overview |
| topic | alkylating agent connective tissue disorders cyclophosphamide vasculitis vesiculobullous disorders |
| url | https://journals.lww.com/10.4103/cdr.cdr_89_23 |
| work_keys_str_mv | AT adityakumarbubna cyclophosphamideanoverview |